Skip to main content
. 2022 Dec 2;12:20816. doi: 10.1038/s41598-022-25413-w

Table 2.

Baseline characteristics in control, prediabetic, and diabetic groups.

Variables Control Prediabetic Diabetic p-value
Number, n (%) 117 (36%) 35 (10.77%) 173 (53.23%)
Age (years) 38.2 ± 10.7 (65.0) 36.0 ± 12.1 (60.0) 48.7 ± 11.7 (85.0) 0.000
Weight (kg) 66.8 ± 11.1 (98.0) 65.8 ± 9.8 (93.5) 63.9 ± 12.1 (105.0) 0.112
Height (cm) 80.1 ± 81.8 (181.0) 106.5 ± 77.1 (176.0) 98.4 ± 76.6 (178.0) 0.085
BMI (kg/m2) 24.6 ± 3.5 (33.0) 24.9 ± 3.0 (31.0) 25.6 ± 4.0 (40.0) 0.049
WC (cm) 85.1 ± 10.4 (110.0) 86.0 ± 9.2 (105.0) 87.1 ± 10.3 (116.0) 0.438
HC (cm) 92.2 ± 8.3 (113.0) 93.7 ± 6.1 (108.0) 91.1 ± 8.2 (113.0) 0.302
SBP (mmHg) 123.0 ± 13.9 (167.0) 130.8 ± 15.8 (160.0) 134.3 ± 18.9 (216.0) 0.000
DBP (mmHg) 82.6 ± 10.8 (118.0) 85.4 ± 11.2 (112.0) 85.2 ± 8.5 (115.0) 0.066
PP (Beats/min) 75.8 ± 11.9 (122.0) 79.6 ± 10.9 (106.0) 83.3 ± 11.2 (124.0) 0.000
FBG (mmol/L) 4.8 ± 0.4 (5.5) 6.0 ± 0.4 (6.8) 10.8 ± 4.5 (26.9) 0.000
XO (U/L) 2.9 ± 1.8 (8.2) 3.7 ± 1.9 (7.8) 5.8 ± 3.6 (18.9) 0.000
SUA (mg/dL) 6.5 ± 1.8 (12.9) 6.1 ± 1.7 (9.6) 4.9 ± 1.9 (10.6) 0.000
Creatinine (mg/dL) 0.9 ± 0.2 (1.3) 0.8 ± 0.2 (1.2) 0.9 ± 0.4 (2.5) 0.631
eGFR (mL/min/1.73 m2) 92.8 ± 16.7 (149.1) 91.1 ± 12.1 (114.2) 86.0 ± 21.4 (147.0) 0.028
SA (g/L) 50.4 ± 14.4 (94.4) 48.4 ± 8.0 (68.4) 42.6 ± 9.2 (67.0) 0.001
TG (mg/dL) 178.2 ± 96.6 (516.4) 183.2 ± 113.5 (474.4) 225.3 ± 138.6 (812.6) 0.006
TC (mg/dL) 204.3 ± 58.1 (426.1) 216.4 ± 67.5 (377.7) 231.9 ± 106.7 (584.0) 0.041
HDL (mg/dL) 32.6 ± 10.9 (82.0) 32.6 ± 8.8 (55.0) 36.6 ± 15.5 (112.4) 0.044
LDL (mg/dL) 136.2 ± 52.9 (317.2) 149.1 ± 57.4 (307.5) 152.1 ± 101.7 (517.2) 0.290

Values are presented as mean ± SD with maximum values in parentheses.

p-values are given for differences in control, prediabetic, and diabetic groups. p-values are obtained from one-way ANOVA.